Add-on Acquisition • Life Science

Novartis Acquires Anthos Therapeutics

On February 11, 2025, Novartis acquired life science company Anthos Therapeutics from The Blackstone Group for 3.0B USD

Acquisition Context
  • This is Novartis’ 28th transaction in the Life Science sector.
  • This is Novartis’ 6th largest (disclosed) transaction.
  • This is Novartis’ 26th transaction in the United States.
  • This is Novartis’ 7th transaction in Massachusetts.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date February 11, 2025
Target Anthos Therapeutics
Sector Life Science
Buyer(s) Novartis
Sellers(s) The Blackstone Group
Deal Type Add-on Acquisition
Deal Value 3.0B USD
Advisor(s) Goldman Sachs
Morgan Stanley (Financial)
Goodwin Procter (Legal)

Target Company

Anthos Therapeutics

Boston, Massachusetts, United States
Anthos Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of genetically and pharmacologically validated therapies for high-risk cardiovascular patient populations. Anthos Therapeutics was founded in 2019 and is based in Boston, Massachusetts.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Novartis

Basel, Switzerland

Category Company
Founded 1996
Sector Life Science
Employees104,323
Revenue 51.8B USD (2024)
DESCRIPTION
Novartis' corporate campus in Basel, Switzerland.
Novartis' corporate campus in Basel, Switzerland.

Novartis is a healthcare and pharmaceutical enterprise dedicated to advancing medical innovation and enhancing patient well-being. Renowned for its pioneering research and development efforts, Novartis has a comprehensive portfolio encompassing groundbreaking pharmaceuticals, generic medications, biosimilars, and eye care solutions. Novartis was founded in 1996 and is based in Basel, Switzerland.


Deal Context for Buyer #
Overall 34 of 36
Sector: Life Science 28 of 30
Type: Add-on Acquisition 30 of 30
State: Massachusetts 7 of 7
Country: United States 26 of 28
Year: 2025 1 of 3
Size (of disclosed) 6 of 20
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-21 Kate Therapeutics

San Diego, California, United States

Kate Therapeutics is a patient-focused biotechnology company developing AAV-based gene therapies to treat genetically defined muscle and heart diseases. Kate Therapeutics was founded in 2020 and is based in San Diego, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-02-26 Novartis - Natural Products and Genetic Strains Assets

Basel, Switzerland

Novartis's Natural Products and Genetic Strains Assets offers cutting-edge biological solutions for farmers.

Sell -

Seller Profile 1

SELLER

The Blackstone Group

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1987
PE ASSETS 394.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

The Blackstone Group is a global alternative investment management firm. The Firm's investment activities span real estate, secondary investments, hedge funds, credit, infrastructure, and private equity. Blackstone's private equity group targets opportunities globally including buyout acquisitions of established companies, development projects, growth equity financings, and industry consolidations. Sectors of interest include automotive, healthcare, chemicals, industrial, commercial property, lodging, communications, media/publishing, consumer & retail, packaging, consumer products, pharmaceuticals, energy, technology, entertainment, telecommunications, financial services, theme parks, food & beverage, and transportation. Blackstone's private equity real estate group looks for opportunities across North/South America, Asia, Australia/New Zealand, and Europe. The real estate group will consider both equity and debt investments. Areas of interest include healthcare, hotel, industrial, office, residential, and retail. The Blackstone Group was formed in 1987 and is based in New York, New York.


Deal Context for Seller #
Overall 184 of 195
Sector: Life Science 5 of 5
Type: Add-on Acquisition 71 of 75
State: Massachusetts 2 of 3
Country: United States 110 of 118
Year: 2025 1 of 12
Size (of disclosed) 17 of 62
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-02-06 AI Fire

Long Beach, California, United States

AI Fire provides fire and life safety services, including inspection, service, customized work orders, and installation for fire alarms, sprinklers, fire extinguishers, and other fire suppression systems. AI Fire was founded in 2009 and is based in Long Beach, California.

Buy $1.1B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-02-24 Stronvar Aerospace

South Windsor, Connecticut, United States

Stronvar Aerospace builds a high-performing group serving the aero-engine supply chain. Stronvar Aerospace is based in South Windsor, Connecticut.

Buy -